November’s reported investments showcase the remarkable range of innovation angel investors are fueling across the ACA community. From organ preservation, surgical navigation, and novel therapies for hemorrhage and skin disease to spatial AI, 3D-printed batteries, workplace analytics, and secure asset control, angel groups are backing companies tackling meaningful challenges in healthcare, energy, cybersecurity, and the built environment. This issue also highlights two positive exits, including one rooted in a Gopher Angels investment made more than a decade ago, underscoring the patient, long-term commitment that makes angel capital such a vital force in turning promising ideas into lasting commercial success.

Investments

1—Summit Technology Laboratory is an Irvine, California based company which is a spatial AI software platform that turns any surface into a wrap-around display in minutes. It received a $250,000 investment from southern California-based TCA Venture Group in Q2, 2026.

2—BMI OrganBank is a Winston Salem, North Carolina-based company that delivers an end-to-end organ preservation platform that supports kidneys  with oxygen and nutrients from point of origin to transplant. It received a $650,000 investment from southern California-based TCA Venture Group in Q1, 2026.

3—Plantbaby, Inc. is a San Diego, California-based company that provides nutritionally complete plant milk for the whole family. It received a $275,000 investment from Naples, Florida-based Tamiami Angel Fund in Q4, 2025.

4—Visie, Inc. is an Austin, Texas-based company that is a 3D computer vision and spatial computing service for use in optical scanners for robotic and navigated orthopedic, neuro, and spine surgery. It received a $110,000 investment from Austin, Texas-based Central Texas Angel Network in Q3, 2026.

5—Cayuga Biotech is a New York City-based company that is developing a first-in-class drug which aims to accelerate the body’s natural clotting to stop major hemorrhage. It received a $445,000 investment from Minneapolis, Minnesota-based Gopher Angels in  Q3, 2026.

6—Alphyn Biologics is a Cincinnati, Ohio-based company that is a clinical stage biotechnology company developing innovative, multi-target topical therapies for challenging skin diseases. It received a $3,718,000 investment from Cincinnati, Ohio-based QCA Ventures in Q3, 2026.

7—Material, Inc. is a Miami, Florida-based company that provides 3D-printed conformal lithium-ion batteries enabling total design freedom. It received a $750,000 investment from San Diego, California-based NuFund Ventures Group in Q2, 2026.

8—Terra Vera is an Albuquerque, New Mexico-based company that develops amino acid-powered oxidative chemistry designed to support living systems. It received a $55,000 investment from Albuquerque, New Mexico-based New Mexico Angels in Q2, 2026.

9—Maptician is a Lincoln, Nebraska-based company that has developed a platform that unifies space planning, and workplace analytics into a single solution built for flexible work. It received a $3,290,000 investment from Lincoln, Nebraska-based Nebraska Angels in Q1, 2026.

10—Long Bridge Medical is a San Francisco, California-based company that operates as a provider of medical affairs, research consulting, and drug development services. It received a $952,220 investment from Boston, Massachusetts-based Sidecar Angels in Q4, 2025. 

11—Goldilock is a London, England-based company that can control physical connection and disconnection of any asset remotely, and instantly without using the internet. It received a $505,000 investment from New York Angels in Q1, 2026.

Exits

1—75F is a Minneapolis, Minnesota-based company that is a cloud native AI enabled building automation platform. It received an $80,000 investment from Minneapolis, Minnesota-based Gopher Angels in 2014 and had a positive exit in Q3, 2026.

2—GoSite is a San Diego, California based company that is a digital marketing suite for home services companies. It received a $100,000 investment from San Diego, California-based NuFund Ventures Group in 2019 and had a positive exit in Q1, 2026.